Leaflet DISTONOCALM 0.2mg / 0.3mg / 15mg / 25mg film-coated tablets
Indicated for: hypertension
Route of administration: oral
Substance: atropine sulfate + ergoton + propranolol + amobarbital sodium (mydriatic + antihypertensive + beta blocker + sedative-hypnotic)
ATC: C07NAN1 (Cardiovascular system | )
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
Use caution if you have glaucoma or increased eye pressure.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
May cause dry mouth, constipation, urinary retention, or blurred vision.
Avoid alcohol during treatment.
May lower blood pressure and increase the risk of falls.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
This combination of atropine sulfate, ergoton, propranolol, and sodium amobarbital is used for the treatment of severe migraines and other vascular disorders. Atropine sulfate reduces muscle spasms, ergoton improves vascular tone, propranolol lowers heart rate, and amobarbital has a sedative effect.
The medication is administered orally or by injection, as directed by a doctor. It is important for patients to follow the prescribed dosage and avoid alcohol consumption during treatment.
Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include drowsiness, dizziness, nausea, and dry mouth. In rare cases, severe reactions such as respiratory depression or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about DISTONOCALM 0.2mg / 0.3mg / 15mg / 25mg
- Substance: atropine sulfate + ergoton + propranolol + amobarbital sodium
- Date of latest medicines list: 01-01-2019
- Product code: W52430002
- Concentration: 0.2mg / 0.3mg / 15mg / 25mg
- Pharmaceutical form: film-coated tablets
- Quantity: 30
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.